Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

715.26 (Glytoucan)

Id:302590a9-ee8b-56ff-9c6e-2f50ec6cc0b9

Glytoucan:G18238GP

Results found

Linked to

	Label	Description
	715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G07707ZV-GLYCOSEQ00101138 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G91768NO-GLYCOSEQ00133157 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G95824JZ-GLYCOSEQ00119126 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G25824CS-GLYCOSEQ00043988 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G68985JM-GLYCOSEQ00120446 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G55583HW-GLYCOSEQ00036843 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G83049TZ-GLYCOSEQ00060847 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G45712QJ-GLYCOSEQ00175713 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	715.26 has motif 6-Sialyl-GalNAc Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G55583HW-GLYCOSEQ00036841 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G07707ZV-GLYCOSEQ00101138 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G91768NO-GLYCOSEQ00133157 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G95824JZ-GLYCOSEQ00119126 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G25824CS-GLYCOSEQ00043988 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G68985JM-GLYCOSEQ00120446 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G55583HW-GLYCOSEQ00036843 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G83049TZ-GLYCOSEQ00060847 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G45712QJ-GLYCOSEQ00175713 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

715.26 has motif 6-Sialyl-GalNAc

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

715.26 has glycosequence GLYGEN.GLYCOSEQUENCE:G55583HW-GLYCOSEQ00036841 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.